v3.24.1.1.u2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total Stockholder's Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Deferred Compensation
Noncontrolling Interests
Total
Beginning Balance at Oct. 31, 2022 $ 684,392 $ 41 $ 2,094,076 $ (1,407,973) $ (1,752) $ (855) $ 855 $ 7,105 $ 691,497
Beginning Balance at (in shares) at Oct. 31, 2022   405,562,988              
Common stock issued, non-employee compensation 68   68           68
Common stock issued, non-employee compensation (in shares)   21,106              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (314)   (314)           (314)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   169,065              
Share based compensation 2,637   2,637           2,637
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation 447       447       447
Adjustment for deferred compensation           (68) 68    
Adjustment for deferred compensation (in shares)   (21,106)              
Reclassification of redeemable non-controlling interest               3,030 3,030
Distribution to noncontrolling interest               (106) (106)
Net Loss (18,622)     (18,622)       (2,464) (21,086)
Ending Balance at Jan. 31, 2023 667,808 $ 41 2,095,667 (1,426,595) (1,305) (923) 923 7,565 675,373
Ending Balance at (in shares) at Jan. 31, 2023   405,732,053              
Beginning Balance at Oct. 31, 2022 684,392 $ 41 2,094,076 (1,407,973) (1,752) (855) 855 7,105 691,497
Beginning Balance at (in shares) at Oct. 31, 2022   405,562,988              
Effect of foreign currency translation                 296
Net loss attributable to noncontrolling interests                 2,072
Net Loss                 (54,997)
Ending Balance at Apr. 30, 2023 638,411 $ 41 2,100,724 (1,460,898) (1,456) (923) 923 7,814 646,225
Ending Balance at (in shares) at Apr. 30, 2023   406,738,713              
Beginning Balance at Jan. 31, 2023 667,808 $ 41 2,095,667 (1,426,595) (1,305) (923) 923 7,565 675,373
Beginning Balance at (in shares) at Jan. 31, 2023   405,732,053              
Sale of common stock, net of fees 2,663   2,663           2,663
Sale of common stock, net of fees (in shares)   949,438              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   57,222              
Share based compensation 3,194   3,194           3,194
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation (151)       (151)       (151)
Distribution to noncontrolling interest               (143) (143)
Net loss attributable to noncontrolling interests                 (392)
Net Loss (34,303)     (34,303)       392 (33,911)
Ending Balance at Apr. 30, 2023 638,411 $ 41 2,100,724 (1,460,898) (1,456) (923) 923 7,814 646,225
Ending Balance at (in shares) at Apr. 30, 2023   406,738,713              
Beginning Balance at Oct. 31, 2023 682,493 $ 45 2,199,661 (1,515,541) (1,672) (1,078) 1,078 17,955 $ 700,448
Beginning Balance at (in shares) at Oct. 31, 2023   450,626,862             450,626,862
Common stock issued, non-employee compensation 51   51           $ 51
Common stock issued, non-employee compensation (in shares)   44,398              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (926)   (926)           (926)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   1,235,192              
Share based compensation 2,876   2,876           2,876
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation 33       33       33
Adjustment for deferred compensation           (51) 51    
Adjustment for deferred compensation (in shares)   (44,398)              
Contributions received from sale of noncontrolling interest               25,122 25,122
Distribution to noncontrolling interest               (236) (236)
Net Loss (19,793)     (19,793)       (24,606) (44,399)
Ending Balance at Jan. 31, 2024 663,934 $ 45 2,200,862 (1,535,334) (1,639) (1,129) 1,129 18,235 682,169
Ending Balance at (in shares) at Jan. 31, 2024   451,862,054              
Beginning Balance at Oct. 31, 2023 682,493 $ 45 2,199,661 (1,515,541) (1,672) (1,078) 1,078 17,955 $ 700,448
Beginning Balance at (in shares) at Oct. 31, 2023   450,626,862             450,626,862
Effect of foreign currency translation                 $ (45)
Net loss attributable to noncontrolling interests                 30,122
Net Loss                 (82,055)
Ending Balance at Apr. 30, 2024 639,806 $ 46 2,208,951 (1,567,474) (1,717) (1,164) 1,164 12,294 $ 652,100
Ending Balance at (in shares) at Apr. 30, 2024   458,406,776             458,406,776
Beginning Balance at Jan. 31, 2024 663,934 $ 45 2,200,862 (1,535,334) (1,639) (1,129) 1,129 18,235 $ 682,169
Beginning Balance at (in shares) at Jan. 31, 2024   451,862,054              
Sale of common stock, net of fees 5,893 $ 1 5,892           5,893
Sale of common stock, net of fees (in shares)   6,463,716              
Common stock issued, non-employee compensation 47   47           47
Common stock issued, non-employee compensation (in shares)   46,357              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (52)   (52)           (52)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   68,597              
Share based compensation 3,002   3,002           3,002
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation (78)       (78)       (78)
Adjustment for deferred compensation           (35) 35    
Adjustment for deferred compensation (in shares)   (33,948)              
Distribution to noncontrolling interest               (425) (425)
Net loss attributable to noncontrolling interests                 5,516
Net Loss (32,140)     (32,140)       (5,516) (37,656)
Ending Balance at Apr. 30, 2024 $ 639,806 $ 46 $ 2,208,951 $ (1,567,474) $ (1,717) $ (1,164) $ 1,164 $ 12,294 $ 652,100
Ending Balance at (in shares) at Apr. 30, 2024   458,406,776             458,406,776